帕金森病睡眠下与清醒下脑深部电刺激的临床结局比较
本研究比较了帕金森病患者在睡眠下(影像引导)与清醒下(微电极记录引导)脑深部电刺激(DBS)术后6个月的运动与非运动结局。结果显示,两组在UPDRS III和II改善上无显著差异,但睡眠下DBS在无运动障碍的“on”时间、生活质量、言语流畅性方面更优。
要点
- 睡眠下DBS在运动症状改善上与清醒下DBS相当或更优。
- 睡眠下DBS在言语流畅性和生活质量方面优于清醒下DBS。
- 睡眠下DBS应作为所有适合DBS的帕金森病患者的考虑选项。
核心结论
- 对于帕金森病患者的DBS治疗,睡眠下影像引导植入在6个月运动结局改善上不显著劣于清醒下微电极记录引导植入,且在言语流畅性和生活质量方面更优。
主要发现
- UPDRS III改善在睡眠下DBS组为+14.8±8.9分,清醒下DBS组为+17.6±12.3分,组间差异无统计学意义(p=0.19)。
- UPDRS II改善在睡眠下DBS组为+9.3±2.7分,清醒下DBS组为+7.4±5.8分,组间差异无统计学意义(p=0.16)。
- 无运动障碍的“on”时间改善在睡眠下DBS组为+6.4±3.0小时/天,优于清醒下DBS组的+1.7±1.2小时/天(p=0.002)。
- 生活质量总分在清醒下DBS组改善+18.8±9.4,睡眠下DBS组改善+8.9±11.5; summary index改善睡眠下DBS更优(p=0.004),认知子评分(p=0.011)和沟通子评分(p<0.001)也以睡眠下DBS更优。
- 言语结局在睡眠下DBS组更优:类别流畅性改善+2.77±4.3分 vs 清醒下DBS组-6.31±9.7分(p=0.0012);音位流畅性改善+1.0±8.2分 vs -5.5±9.6分(p=0.038)。
关键数值与推荐
- 睡眠下DBS组无运动障碍的“on”时间改善+6.4±3.0小时/天,清醒下DBS组+1.7±1.2小时/天(p=0.002)。
- 生活质量summary index改善睡眠下DBS更优(p=0.004),认知子评分(p=0.011)和沟通子评分(p<0.001)也以睡眠下DBS更优。
- 言语类别流畅性改善睡眠下DBS组+2.77±4.3分,清醒下DBS组-6.31±9.7分(p=0.0012);音位流畅性改善睡眠下DBS组+1.0±8.2分,清醒下DBS组-5.5±9.6分(p=0.038)。
临床怎么用
- 对于适合DBS的帕金森病患者,睡眠下影像引导DBS可作为考虑选项,尤其关注言语流畅性和生活质量改善时。
局限性
- 本研究为Class III证据,非随机对照设计,睡眠下DBS组为前瞻性纳入,清醒下DBS组为既往对照,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare motor and nonmotor outcomes at 6 months of asleep deep brain stimulation (DBS) for Parkinson disease (PD) using intraoperative imaging guidance to confirm electrode placement vs awake DBS using microelectrode recording to confirm electrode placement. METHODS: DBS candidates with PD referred to Oregon Health & Science University underwent asleep DBS with imaging guidance. Six-month outcomes were compared to those of patients who previously underwent awake DBS by the same surgeon and center. Assessments included an "off"-levodopa Unified Parkinson's Disease Rating Scale (UPDRS) II and III, the 39-item Parkinson's Disease Questionnaire, motor diaries, and speech fluency. RESULTS: Thirty participants underwent asleep DBS and 39 underwent awake DBS. No difference was observed in improvement of UPDRS III (+14.8 ± 8.9 vs +17.6 ± 12.3 points, p = 0.19) or UPDRS II (+9.3 ± 2.7 vs +7.4 ± 5.8 points, p = 0.16). Improvement in "on" time without dyskinesia was superior in asleep DBS (+6.4 ± 3.0 h/d vs +1.7 ± 1.2 h/d, p = 0.002). Quality of life scores improved in both groups (+18.8 ± 9.4 in awake, +8.9 ± 11.5 in asleep). Improvement in summary index (p = 0.004) and subscores for cognition (p = 0.011) and communication (p < 0.001) were superior in asleep DBS. Speech outcomes were superior in asleep DBS, both in category (+2.77 ± 4.3 points vs -6.31 ± 9.7 points (p = 0.0012) and phonemic fluency (+1.0 ± 8.2 points vs -5.5 ± 9.6 points, p = 0.038). CONCLUSIONS: Asleep DBS for PD improved motor outcomes over 6 months on par with or better than awake DBS, was superior with regard to speech fluency and quality of life, and should be an option considered for all patients who are candidates for this treatment. CLINICALTRIALSGOV IDENTIFIER: NCT01703598. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with PD undergoing DBS, asleep intraoperative CT imaging-guided implantation is not significantly different from awake microelectrode recording-guided implantation in improving motor outcomes at 6 months.
引用
- Brodsky MA, Anderson S, Murchison C, et al. Clinical outcomes of asleep vs awake deep brain stimulation for Parkinson disease. Neurology. 2017. PMID: 28986415. doi:10.1212/WNL.0000000000004630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。